EV/EBITDA (Enterprise Value to EBITDA) in Pharmaceuticals & Healthcare
How to interpret and apply ev/ebitda (enterprise value to ebitda) specifically when analyzing pharmaceuticals & healthcare stocks in India.
Quick Recap: What is EV/EBITDA (Enterprise Value to EBITDA)?
EV/EBITDA is a valuation metric that compares a company's total enterprise value to its operating earnings, removing the effects of debt, taxes, and accounting choices.
EV/EBITDA = (Market Cap + Debt - Cash) ÷ EBITDA
How EV/EBITDA (Enterprise Value to EBITDA) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
Typical P/E (related)20-40x
General benchmark: 8-12x for most industries. Lower for cyclicals, higher for tech/growth.
Example Pharmaceuticals & Healthcare Companies to Analyze
Use the Equiscale Screener → to filter pharmaceuticals & healthcare stocks by ev/ebitda and other metrics.
Key Takeaways
- EV/EBITDA (Enterprise Value to EBITDA) in pharmaceuticals & healthcare should be compared against sector peers, not the market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Always cross-check with other metrics. No single ratio tells the full story.